Results per Page:
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Successful long-term outcomes for unrelated bone marrow transplants
From the Deeg Lab, Clinical Research Division
Gut microbes dictate donor T cell expansion and graft-versus-host disease risk after stem cell transplantation
From the Hill Lab, Translational Science and Therapeutics Division
Caregivers know compassion is critical; staying organized is, too
One woman shares tips on caring for a spouse going through blood cancer treatment
The interplay between intestinal microbiota and graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Outcome predictions for patients with graft-versus-host disease
From the Hematopoietic Cell Transplantation Program, Clinical Research Division
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
HLA-B leader sequences influence graft-versus-host-disease
From the Petersdorf laboratory, Clinical Research Division
Commensals turn pathogenic in graft-vs-host disease
From the University of Michigan and the Fredricks Lab, Vaccine and Infectious Disease Division
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
Landmark scientific paper turns 40
First unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy, modern bone marrow transplantation